newsFirst COVID-19 patient dosed in Phase II trial of Quellor16 November 2020 | By Victoria Rees (European Pharmaceutical Review)The first patient has been dosed with Quellor in a Phase II clinical trial, evaluating the drug for the treatment of pulmonary complications from COVID-19.